Brain lipid changes after repetitive transcranial magnetic stimulation: Potential links to therapeutic effects?

Metabolomics

Volumn 8, Issue 1, 2012, Pages 19-33

  Lee, Lynette Hui Wen ^a   Tan, Chay Hoon ^a   Lo, Yew Long ^b   Farooqui, Akhlaq A ^c   Shui, Guanghou ^a   Wenk, Markus R ^a   Ong, Wei Yi ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Depression; Frontal cortex; Lipids; Pain; Plasmalogens; Polyunsaturated fatty acids; Sulfatide; Transcranial magnetic stimulation

Indexed keywords

CERAMIDE; DOCOSAHEXAENOIC ACID; GALACTOSYLCERAMIDE; LIPID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLSERINE; MESSENGER RNA; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PLASMALOGEN; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN; SULFATIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; HIPPOCAMPUS; LEFT HEMISPHERE; LIPID ANALYSIS; LIPID BRAIN LEVEL; LIPIDOMICS; MALE; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; TANDEM MASS SPECTROMETRY; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

RATTUS;

EID: 84855874380     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0285-4     Document Type: Article

References (53)

1. Adibhatla, R. M., and Hatcher, J. F. (2007). Role of lipids in brain injury and diseases. Future Lipidology, 2, 403-422.
2. Adibhatla, R. M., Hatcher, J. F., and Dempsey, R. J. (2006). Lipids and lipidomics in brain injury and diseases. AAPS Journal, 8, E314-E321.
3. Aizenstein, H. J., Butters, M. A., Figurski, J. L., Stenger, V. A., Reynolds, C. F., I. I. I., and Carter, C. S. (2005). Prefrontal and striatal activation during sequence learning in geriatric depression. Biological Psychiatry, 58, 290-296.
4. Avery, D. H., Isenberg, K. E., Sampson, S. M., et al. (2008). Transcranial magnetic stimulation in the acute treatment of major depressive disorder: Clinical response in an open-label extension trial. Journal of Clinical Psychiatry, 69, 441-451.
5. Bazan, N. G. (2009). Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukotrienes and Essential Fatty Acids, 81, 205-211.
6. Bestmann, S. (2008). The physiological basis of transcranial magnetic stimulation. Trends in Cognitive Sciences, 12, 81-83.
7. Bligh, E. G., and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911-917.
8. Bloch, Y., Grisaru, N., Harel, E. V., et al. (2008). Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: An open-label study. Journal of ECT, 24, 156-159.
9. Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., and Artigas, F. (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. Journal of Neuroscience, 21, 9917-9929.
10. Cotelli, M., Manenti, R., Cappa, S. F., et al. (2006). Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Archives of Neurology, 63, 1602-1604.
11. DeMar, J. C., Jr., Ma, K., Bell, J. M., Igarashi, M., Greenstein, D., and Rapoport, S. I. (2006). One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. Journal of Lipid Research, 47, 172-180.
12. Drevets, W. C. (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research, 126, 413-431.
13. Eckhardt, M. (2008). The role and metabolism of sulfatide in the nervous system. Molecular Neurobiology, 37, 93-103.
14. Eschweiler, G. W., Wegerer, C., Schlotter, W., et al. (2000). Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Research, 99, 161-172.
15. Farooqui, A. A. (1981). Metabolism of sulfolipids in mammalian tissues. Advances in Lipid Research, 18, 159-202.
16. Farooqui, A. A. (2009). Lipid mediators in the neural cell nucleus: Their metabolism, signaling, and association with neurological disorders. Neuroscientist, 15, 392-407.
17. Farooqui, A. A., and Horrocks, L. A. (2001). Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue. Journal of Molecular Neuroscience, 16, 263-272. (discussion 279-284).
18. Feng, H. L., Yan, L., and Cui, L. Y. (2008). Effects of repetitive transcranial magnetic stimulation on adenosine triphosphate content and microtubule associated protein-2 expression after cerebral ischemia-reperfusion injury in rat brain. Chinese Medical Journal (English), 121, 1307-1312.
19. Fitzgerald, P. (2008). Brain stimulation techniques for the treatment of depression and other psychiatric disorders. Australas Psychiatry, 16, 183-190.
20. Fujiki, M., and Steward, O. (1997). High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. Brain Research Molecular Brain Research, 44, 301-308.
21. George, M. S., Lisanby, S. H., Avery, D., et al. (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Archives of General Psychiatry, 67, 507-516.
22. Guan, X. L., He, X., Ong, W. Y., Yeo, W. K., Shui, G., and Wenk, M. R. (2006). Non-targeted profiling of lipids during kainate-induced neuronal injury. FASEB Journal, 20, 1152-1161.
23. Han, X., Cheng, H., Fryer, J. D., Fagan, A. M., and Holtzman, D. M. (2003). Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. The Journal of Biological Chemistry, 278, 8043-8051.
24. Han, X., Holtzman, D. M., McKeel, D. W., Jr., Kelley, J., and Morris, J. C. (2002). Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis. Journal of Neurochemistry, 82, 809-818.
25. Honke, K., Zhang, Y., Cheng, X., Kotani, N., and Taniguchi, N. (2004). Biological roles of sulfoglycolipids and pathophysiology of their deficiency. Glycoconjugate Journal, 21, 59-62.
26. Ishizuka, I. (1997). Chemistry and functional distribution of sulfoglycolipids. Progress in Lipid Research, 36, 245-319.
27. Ji, R. R., Schlaepfer, T. E., Aizenman, C. D., et al. (1998). Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proceedings of the National Academy of Sciences of the United States of America, 95, 15635-15640.
28. Kapogiannis, D., and Wassermann, E. M. (2008). Transcranial magnetic stimulation in clinical pharmacology. Central Nervous System Agents in Medicinal Chemistry, 8, 234-240.
29. Kim, E. J., Kim, W. R., Chi, S. E., et al. (2006). Repetitive transcranial magnetic stimulation protects hippocampal plasticity in an animal model of depression. Neuroscience Letters, 405, 79-83.
30. Koch, G., and Rothwell, J. C. (2009). TMS investigations into the task-dependent functional interplay between human posterior parietal and motor cortex. Behavioural Brain Research, 202, 147-152.
31. Koos, T., and Tepper, J. M. (1999). Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nature Neuroscience, 2, 467-472.
32. Lee, L. H., Shui, G., Farooqui, A. A., Wenk, M. R., Tan, C. H., and Ong, W. Y. (2009). Lipidomic analyses of the mouse brain after antidepressant treatment: Evidence for endogenous release of long-chain fatty acids? The International Journal of Neuropsychopharmacology, 10, 1-12.
33. Lefaucheur, J. P. (2009). Methods of therapeutic cortical stimulation. Neurophysiologie Clinique, 39, 1-14.
34. Lefaucheur, J. P., Hatem, S., Nineb, A., et al. (2006). Somatotopic organization of the analgesic effects of motor cortex rTMS in neuropathic pain. Neurology, 67, 1998-2004.
35. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
36. Mozzi, R., and Buratta, S. (2010). Brain phosphatidylserine: Metabolism and functions. In A. Lajtha, G. Tettamanti, and G. Goracci (Eds.), Handbook of neurochemistry and molecular neurobiology: Neural lipids (pp. 39-59). New York: Springer.
37. Muller, M. B., Toschi, N., Kresse, A. E., Post, A., and Keck, M. E. (2000). Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology, 23, 205-215.
38. O'Reardon, J. P., Solvason, H. B., Janicak, P. G., et al. (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biological Psychiatry, 62, 1208-1216.
39. Padberg, F., Zwanzger, P., Keck, M. E., et al. (2002). Repetitive transcranial magnetic stimulation (rTMS) in major depression: Relation between efficacy and stimulation intensity. Neuropsychopharmacology, 27, 638-645.
40. Pascual-Leone, A., Rubio, B., Pallardo, F., and Catala, M. D. (1996). Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet, 348, 233-237.
41. Paxinos, G., and Watson, C. (1986). The rat brain in stereotaxic coodinates. Sydney: Academic Press.
42. Ramakrishnan, H., Hedayati, K. K., Lullmann-Rauch, R., et al. (2007). Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. Journal of Neuroscience, 27, 9482-9490.
43. Rao, J. S., Ertley, R. N., Lee, H. J., et al. (2007). n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Molecular Psychiatry, 12, 36-46.
44. Rossi, S., Pasqualetti, P., Rossini, P. M., et al. (2000). Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans. Cerebral Cortex, 10, 802-808.
45. Sachdev, P. S., Loo, C. K., Mitchell, P. B., McFarquhar, T. F., and Malhi, G. S. (2007). Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: A double-blind controlled investigation. Psychological Medicine, 37, 1645-1649.
46. Sapolsky, R. M. (2001). Depression, antidepressants, and the shrinking hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 98, 12320-12322.
47. Schutter, D. J. (2009). Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: A meta-analysis. Psychological Medicine, 39, 65-75.
48. Shui, G., Bendt, A. K., Pethe, K., Dick, T., and Wenk, M. R. (2007). Sensitive profiling of chemically diverse bioactive lipids. Journal of Lipid Research, 48, 1976-1984.
49. van Zyl, R., Gieselmann, V., and Eckhardt, M. (2010). Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice. Journal of Neurochemistry, 112, 282-295.
50. Vance, J. E. (2008). Phosphatidylserine and phosphatidylethanolamine in mammalian cells: Two metabolically related aminophospholipids. Journal of Lipid Research, 49, 1377-1387.
51. Watson, A. D. (2006). Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: A global approach to lipid analysis in biological systems. Journal of Lipid Research, 47, 2101-2111.
52. Wenk, M. R. (2005). The emerging field of lipidomics. Nature Reviews Drug Discovery, 4, 594-610.
53. Ziemann, U. (2004). TMS induced plasticity in human cortex. Reviews in the Neurosciences, 15, 253-266.